App-Quantinova.ai

Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data

Alexander Cohen - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Enoxaparin

Discovery of a Novel, Potent, Selective and Injectable Small Molecule Inhibitor of Blood Coagulation Factor XIa, ONO-8610539: in Vitro and in Vivo Pharmacological Profiles

Masashi Gohda - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ONO8610539

Anti-Apoptotic Effects of Platelet Factor 4 on Human T-Lymphocytes

Yulia V. Skibo - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

streptomycin

Arterial and Venous Thrombosis: Clinical Evidence for Mechanistic Overlap

Walter Ageno - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Warfarin

Basic Mechanisms of Arterial and Venous Thrombosis

Thomas Renne - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hemostatic Solution

Animal Models of Arterial and Venous Thrombosis

Bruce Furie - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

quercetin

Dose Escalation Phase 2 Trial of Carfilzomib Combined with Thalidomide and Low-Dose Dexamethason in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma. a Trial of the European Myeloma Network

Pieter Sonneveld - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Cyclophosphamide

Critical Role of T Cells in PF4/Heparin Antibody Production

Yongwei Zheng - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Infusion of Red Blood Cell-Derived Microparticles (RMPs) Reduced Intracerebral Bleeding Following Hemorrhagic Stroke in a Rat Model

Kunjan R Dave - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Collagenase

A Prospective Phase II Trial of Lenalidomide and Dexamethasone ( LEN-DEX) in POEMS Syndrome

Arnaud Jaccard - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Dexamethasone

Neutrophils in Deep Venous Thrombosis

Thomas W. Wakefield - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Methadone hydrochloride

Neutrophil Extracellular Traps and von Willebrand Factor in Thrombosis

Denisa D. Wagner - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

N/A

Innate Immunity, Coagulation, and Thrombosis

Bernd Engelmann - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Elaszym

Reduced Polyethylene Glycol-Conjugated B-DomainDeleted Factor VIII (PEG-BDD-FVIII) Clearance: Selective Peg Steric Modulation without Affecting Potency

Eric Blasko - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

BAY 94-9027

Trends of Venous Thromboembolism (VTE) and Risk Factors for Developing VTE in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT) in childrens Hospitals-a PHIS Database Study

Surabhi Batra - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Levels of Circulating Alternatively Spliced Tissue Factor (asTF) in the Plasma of Patients with Pancreatic Ductal Adenocarcinoma (PDAC) May Help Predict Aggressive Tumor Phenotype

Dusten Unruh - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Dextrose Intravenous

Distinct Localization of Coagulation Factor VIII, Von Willebrand Factor and Factor VIIIa-Mimetic Bispecific Antibody Contributing to Thrombus Formation Under Whole Blood Flow Conditions

Yasuaki Shida - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

FVIII

Identification of a Racially Dimorphic Variant in the Human Platelet PAR4 Thrombin Receptor Altering Platelet Function and Pharmacologic Inhibition

Leonard C. Edelstein - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Phosphatidylinositol

12-HETrE, a Novel 12-LOX Oxylipin, Prevents Platelet Activation in a G?s-like Manner

Jennifer Yeung - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Prostacyclin

Platelet Factor 4 Enables Platelets to Suppress Early Parasite Growth in a Mouse Model of Blood Stage Malarial Infection

Brendan John McMorran - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

Heparin

Filters

7277 Abstracts